NCT00002003View on ClinicalTrials.gov

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Lymphoma, Non-HodgkinHIV Infections
Interventions
DRUG

Mitoxantrone hydrochloride

DRUG

Etoposide

Trial Locations (3)

10016

New York Univ Med Ctr, New York

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

071032714

UMDNJ - New Jersy Med School, Newark

Sponsors
All Listed Sponsors
lead

Lederle Laboratories

INDUSTRY

NCT00002003 - Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas | Biotech Hunter | Biotech Hunter